Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Dec;86(6):673-80.
doi: 10.1016/j.contraception.2012.05.012. Epub 2012 Jul 6.

Results from pooled Phase III studies of ulipristal acetate for emergency contraception

Caroline Moreau  1 , James Trussell
Affiliations
Clinical Trial

Results from pooled Phase III studies of ulipristal acetate for emergency contraception

Caroline Moreau et al. Contraception. 2012 Dec.

Abstract

Background: Ulipristal acetate (UPA) is a new effective option to prevent unintended pregnancies up to 5 days after unprotected intercourse. We used pooled data from two Phase III studies to refine our understanding of the efficacy of UPA by time from unprotected intercourse and the effects of other factors on pregnancy rates.

Study design: Data from two Phase III studies were pooled to create a larger analysis population. Analyses were performed on the first participation of 2183 women.

Results: A total of 41 women became pregnant despite the use of UPA, yielding an overall proportion pregnant of 1.9% (1.3%-2.5%). Proportions of pregnant women were higher among those with further acts of unprotected intercourse in the same cycle and among obese women. These varied from 1.3% (0.9%-2.0%) among nonobese women who had no further acts of unprotected intercourse (n=1704) to 8.3% (0.2%-38.5%) among obese women who had subsequent unprotected intercourse (n=12).

Conclusions: UPA is effective and safe in preventing pregnancy after unprotected intercourse. Its effectiveness is lower among women who have subsequent unprotected intercourse and among obese women.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study populations of EC with UPA.
Fig. 2
Fig. 2
Percentage pregnant (▲) and 95% CI (vertical lines) by 24-h intervals — UPI to UPA treatment.
Fig. 3
Fig. 3
Frequency of reported symptoms following UPA intake.
Fig. 4
Fig. 4
Distribution of change in cycle length from cycle length reported at screening: median change +1 day.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Raymond E, Taylor D, Trussell J, Steiner MJ. Minimum effectiveness of the levonorgestrel regimen of emergency contraception. Contraception. 2004;69:79–81. - PubMed
    1. Piaggio G, Kapp N, von Hertzen H. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception. 2011;84:35–9. - PubMed
    1. Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012 http://dx.doi.org/10.1093/humrep/des140. - DOI - PMC - PubMed
    1. Fine P, Mathé H, Ginde S, Cullins V, Morfesis J, Gainer E. Ulipristal acetate taken 48–120 hours after intercourse for emergency contraception. Obstet Gynecol. 2010;115:257–63. - PubMed
    1. Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375:555–62. - PubMed

Publication types

MeSH terms

LinkOut - more resources